Want to join the conversation?
$IR 2Q15 PR: 3Q15 Outlook: Organic revenues to increase in range of 5- 6% & reported revenues are expected to be up 4-5%. Adjusted EPS from continuing operations to be $1.15-1.19, with reported EPS of $1.13-1.17. Restructuring expenses are expected to approx. $0.02 per share; tax rate of 25% and average diluted share count of approx. 270MM shares.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)